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Aim: To discriminate the most important physicochemical parameters for bone 
reconstruction, the inflammatory potential of seven nanoporous hydroxyapatite 
powders synthesized by hard or soft templating was evaluated both in vitro and 
in vivo. Materials & methods: After physical and chemical characterization of the 
powders, we studied the production of inflammatory mediators by human primary 
monocytes after 4 and 24 h in contact with powders, and the host response after 
2 weeks implantation in a mouse critical size defect model. Results: In vitro results 
highlighted increases in the secretion of TNF-α, IL-1, -8, -10 and proMMP-2 and -9 
and decreases in the secretion of IL-6 only for powders prepared by hard templating. 
In vivo observations confirmed an extensive inflammatory tissue reaction and a strong 
resorption for the most inflammatory powder in vitro. Conclusion: These findings 
highlight that the most critical physicochemical parameters for these nanoporous 
hydroxyapatite are, the crystallinity that controls dissolution potential, the specific 
surface area and the size and shape of crystallites.
Keywords:  bone substitutes • critical size defects • inflammation • mice • monocytes 
• nanoporous calcium phosphates 
Calcium phosphate bioceramics and espe-
cially hydroxyapatite (HA) have long been 
used as bone substitute [1]. In fact, even 
though autologous graft remains the gold 
standard, the use of bioceramics may reduce 
the duration of surgery and the morbidity 
for bone defect filling and other orthope-
dic procedures [2]. After implantation, the 
interaction between HA and the host tissues 
leads to a dissolution/precipitation process 
and cell colonization by both inflammatory 
cells (monocytes/macrophages) and bone 
resident cells (osteoblasts and osteoclasts). 
Calcium-phosphate resorption allows new 
bone formation thanks to its scaffold func-
tion and osteoconductive properties [3]. An 
ideal calcium-phosphate biomaterial would 
need to stay long enough to drive new bone 
formation, but should be resorbed for newly 
formed bone to take its place, instead of frag-
menting and becoming deleterious. When 
HA and other biomaterials are implanted 
into a bone defect, a host response is always 
expected as a first step in tissue repair. This 
host response is a cascade of events that starts 
immediately after implantation and has been 
widely reviewed [4,5]. The implantation trig-
gers an inflammatory response that begins 
with the adsorption of blood proteins on the 
biomaterial surface and initiates coagulation 
and the arrival of platelets and immune cells 
in the site. In the acute phase of inflamma-
tion within the first days after implantation, 
the wound site is cleaned by neutrophils that 
secrete proinflammatory cytokines and che-
moattractants to promote their phagocytic 
activity and the chemotaxis of mononuclear 
cells [6]. However, in the long term, the 
remnants of the biomaterial and its released 
particles can lead to chronic inflammation 
accompanied by tissue destruction, fibrosis 
and necrosis. In fact, HA particles are known 
to trigger inflammatory events due to their 
limited resorption capability [7]. Such an 
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effect is mediated mostly by the production of inflam-
matory mediators from monocytes/macrophages 
which attempt to clear the biomaterial. Among these 
mediators, IL-1β, IL-6 and TNF-α are powerful pro-
inflammatory cytokines that can activate and amplify 
the inflammatory reaction by an increased release of 
proteases and cytokines/chemokines and a contribu-
tion to exacerbated osteoclastogenesis [8,9]. The above 
mentioned mediators can also activate the endothe-
lium leading to an inflammatory cell influx from the 
blood flow [10]. This influx is increased by the chemo-
kines gradient created from the implant site in response 
to the proinflammatory cytokines and by the increased 
fragility of the vascular wall as a result of the action 
of proteases [11,12]. In physiological conditions when 
inflammation is maximal, the latter is counterbalanced 
by the production of anti-inflammatory molecules 
(e.g., IL-10) so as to return to a homeostatic state. For 
this reason, the balance between pro- and anti-inflam-
matory factors in the vicinity of the implanted material 
is crucial for the control of angiogenesis, osteoclasto-
genesis, bone resorption and bone remodeling [13]. In 
addition, the physicochemical properties of calcium 
phosphate can also greatly impact the fate of ceram-
ics in the host as they condition the cellular response 
[14–16]. In particular it has been demonstrated that 
physicochemical characteristics such as surface area 
ratio, shape and size of hydroxyapatite particles influ-
enced significantly cytokines production by human 
monocytes but also their uptake and subsequent toxic-
ity in vitro [17–21]. Actually, it is now possible to control 
particle size and size distribution of HA crystals from 
the nano- to the macro-scale with various shapes from 
the zero-dimensional shape of particles and spheres, 
the one-dimensional shapes of rods and fibers, the 
two-dimensional shape of sheets, plates and the three-
dimensional shapes of porous, hollow and biomimetic 
structures similar to biological bone and teeth [22]. The 
work presented herein is part of a program developing 
HA-based scaffolds as growth factor carriers for bone 
filling purpose. Indeed, nowadays one of the most 
challenging research areas in musculoskeletal disor-
der treatments is how to effectively induce new bone 
formation for fracture healing and bone fusion. This 
can be achieved by controlling the sustained release 
of osteogenic factors such as bone morphogenetic pro-
teins or angiogenic factors such as VEGF [23,24]. One 
possibility to achieve this is to develop nanoporous 
hydroxyapatite having pore diameters close to the size 
of the growth factor molecules. With this objective in 
mind, we built seven nanoporous calcium-phosphate 
samples using two different synthesis techniques, that 
is soft and hard templating. Soft templating which can 
be performed with or without the addition of ionic or 
nonionic surfactants requires heat treatment in order 
to remove them from synthesized nanoporous HA [25]. 
Hard templating was thus used as an alternative to 
produce controlled porosity and consisted in the fill-
ing of a nanoporous mold (mesocellular silica foam or 
repeated templating via a carbon replica) with precur-
sors of the required material. Finally, HA ceramics were 
obtained with an interparticular mesoporous structure 
[26]. Other approaches for synthesizing nanoporous 
HA can be used such as colloidal crystal templating 
using polymer spheres or monodisperse nanocrystal-
line assembly. However, colloidal crystal templating 
would not be pertinent here since the porosity pro-
duced is rather macroporous, in other words, much 
larger than the growth factors. Similarly, the com-
parison with monodisperse nanocrystalline assembly 
would not bring enough added-value compared with 
our nanocrystalline assembly in terms of growth fac-
tors trapping and osteointegration. Herein, the inflam-
matory potential of such HA powders was investigated 
using a rarely used combined approach, in other words, 
on freshly elutriated human monocytes in vitro and in 
a critical size femoral condyle defect in mice to cor-
relate in vitro cytokines and proteinases production 
and in vivo histological observations. The results were 
analyzed with regard to physicochemical properties of 
the HA powders which could be modulated to improve 
bone regeneration.
Materials & methods
HA synthesis by soft templating
Mesoporous apatites were obtained by adapting a wet 
chemistry method previously described [25]. Lime 
(Ca[OH]
2
) was dispersed at 25°C in a 50 ml ethanol-
water solution (50%, v/v), then stirred for 3 h to dis-
solve calcium ions (solubility of lime 1.54 g.l-1). An 
aqueous solution of ammonium dihydrogeno-phos-
phate ([NH
4
]H
2
PO
4
, 6.7% w/v) was prepared and 
slowly added in order to reach a final Ca/P ratio of 
1.67 (stoichiometric HA). The pH of the solution was 
adjusted to 11 and the final mixture was stirred at room 
temperature for 20 h. For sample HA1, the suspension 
was directly lyophilized. For sample HA2, the suspen-
sion was filtered and dried at 100°C overnight. These 
HA powders were washed with ethanol and water and 
then sintered at 650°C for 6 h.
HA3 and HA4 powder synthesis was derived from 
a coprecipitation method using a surfactant [27]. Aque-
ous solutions of calcium pantothenate (0.5 M) and 
dipotassium hydrogen phosphate (K
2
HPO
4
, pH = 11) 
were prepared separately in order to obtain a final 
ratio of Ca/P = 1.67. A solution of three millimolar 
nonionic surfactant pluronic F127® (Sigma-Aldrich, 
Saint-Quentin Fallavier, France) was prepared in water 
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by vigorous stirring in order to obtain a clear micel-
lar solution. The calcium solution was first added to 
the surfactant solution. Then the K
2
HPO
4
 solution 
was slowly added to the F127/Ca2+ solution. This final 
solution was heated under reflux at 80°C for 24 h to 
obtain a white powder. The solid was then filtered, 
dried at 100°C overnight, washed with ethanol and 
water and sintered at 650°C for 6 h (HA3 powder) or 
washed many times with ethanol and water before sin-
tering at 300°C for 10 h (HA4 powder). All chemicals 
were from Sigma-Aldrich, Lyon, France.
HA synthesis by hard templating
The hard templating syntheses of HA powders used 
in this study were recently published [26]. Briefly, 
nanoporous silica foams were synthesized according 
to Schmidt-Winkel et al. [28]. Nanoporous carbon 
was obtained by replication of these silicas through 
chemical vapour deposition [29]. Nanoporous HA was 
obtained by infiltrating nanoporous silica or carbon 
(‘templates’) with aqueous solution of calcium nitrate 
and prehydrolized triethyl phosphite. For this study, 
three different samples were prepared: sample HA5 
was infiltrated into nanoporous silica and the silica 
template was removed without sintering by eliminat-
ing the template in an alkaline medium (refluxing 
with NaOH one molar in ethanol/water [v/v]) [26]. 
Sample HA6 was infiltrated into a silica template and 
sintered at 500°C in air for 12 h before the template 
was removed. Of note, energy-dispersive x-ray (EDX) 
analysis demonstrated that only approximately 1% 
metallic silicon was left after the procedure (data not 
shown). Sample HA7 was infiltrated into a nanopo-
rous carbon template and sintered at 500°C in air for 
12 h. The heat treatment combined both sintering and 
template removal.
Methods for characterization of HA powders
For the phase composition investigation, powders were 
analyzed with an x-ray diffractometer D5000 (Sie-
mens, Munich, Germany). The x-ray pattern data were 
collected from 2θ = 15° to 70° using a monochromatic 
CuKα radiation at 0.04 degree steps with a count time 
of 12 s at each step. The calcium phosphate structures 
were identified according to the Joint Committee on 
Powder Diffraction Standards files, and the percentage 
of crystallinity was determined according to standard 
ISO 13779-3 [30]. Nitrogen adsorption and desorption 
isotherms were measured at 77 K on a Autosorb-MP1 
surface area analyzer (Quantachrome Instruments, 
FL, USA) after 14 h outgassing at 398 K. The spe-
cific surface area was determined from the adsorption 
curves by the Brunauer-Emmet-Teller method [31], 
while pore size and volume were calculated from the 
desorption curves using the Barrett–Joyner–Halenda 
method [32]. The ζ-potential was measured in water 
at 25°C using freshly prepared dispersions (0.5 g.ml-1) 
after 5 min of sonication on a Zetasizer NanoZS (Mal-
vern Instruments, Worcestershire, UK). After stabili-
zation (1 min), the sample was measured using an ini-
tial voltage of 1.2 mV. The ζ-potential was calculated 
using the built-in software based on the Smoluchowski 
formula [33].
Transmission electron microscopy was carried out 
on a Philips CM 200 (Philips, Eindhoven, The Neth-
erlands) with an acceleration voltage of 20 kV. Samples 
were prepared by dispersing the powder in chloroform 
using sonication, putting a drop of the dispersion onto 
an observation grid and drying at room temperature.
Particle dimensions (long axis -L-, short axis -S- and 
aspect ratio [AR] -L/S-) were obtained by manual mea-
surements of at least 70 particles using ImageJ software 
from transmission electron microscopy micrographs.
In order to determine their bioactivity, HA powders 
were immersed in RPMI-1640 Glutamax™ medium 
(Life Technologies, Saint Aubin, France) for 30 min, 1, 
2, 4, 12 h and 1, 2, 4, 8 and 14 days. After each period, 
supernatants were collected and total concentrations of 
Ca and P inside the samples were measured by induc-
tively coupled plasma-optical emission spectroscopy 
(ICP-OES) using an iCAP 6300 duo plasma emission 
spectrometer (Thermo Scientific, Illkirch, France). 
Standard solutions used for calibration were prepared 
by diluting mono-elemental ICP standard solutions 
of Ca and P (SCP Science, Courtaboeuf, France). 
Ultrapure water (ALPHA Q, 18 MΩ.cm-1) was used 
to prepare standard solutions and dilute samples. Ca 
and P were measured at 184.006 nm with a radial view 
and 177.495 nm using an axial view, respectively. To 
avoid matrix effects, all samples were diluted by a fac-
tor of 125 and yttrium (ICP standard from SCP Sci-
ence) was used as an internal standard to correct dif-
ferences between standards and samples. The subarray 
plots for each wavelength were examined to ensure 
the absence of spectral interferences. Satisfactory cor-
relation coefficients were obtained for linear calibra-
tions of Ca (R = 0.99924) and P (R = 0.99982). The 
limits of detection and quantification were 6.86 and 
22.88 μg.l-1 for Ca and to 0.60 and 2.04 μg.l-1 for P.
Cell culture
Monocytes from seven healthy consenting donors were 
collected by leukapheresis and purified by counter-
flow elutriation [34]. Purity after CD14 staining was at 
least 95%. Cell viability was evaluated by Trypan blue 
exclusion test and was >95% before and after all exper-
imental conditions. Cells were maintained in RPMI-
1640 Glutamax medium supplemented with 10% 
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(v/v) heat inactivated fetal calf serum and 1% peni-
cillin/streptomycin (10,000 U.ml-1 + 10,000 μg.ml-1) 
at 37°C in a 5% CO
2
 humidified atmosphere (all cell 
culture reagents were purchased from Life Technolo-
gies). The cells were cultured in 24-well plates (BD 
Falcon®, Dominique Dutscher, Brumath, France) after 
seeding at a density of 2 × 106 cells.ml-1. In the pres-
ent work, the surface area ratio (SAR = specific surface 
area of material/surface area of cells) method was used 
[35]. Based on our previous data, we used a surface area 
ratio equal to one for all our in vitro experiments [17,18]. 
Each powder was weighed to obtain a surface value of 
2.5 × 10–3 m2 (total cell surface) and then resuspended 
in culture medium before addition of cell suspension. 
As HA powders sedimented more rapidly than cells, 
they laid at the bottom of the wells and cells were situ-
ated on and beside the HA particles. After 4 and 24 h of 
immersion in culture medium, we evaluated HA par-
ticles agglomerates size which ranged from 1 to 80 μm 
for all the seven powders (data not shown). Cells from 
each donor were exposed to the seven HA powders 
separately for 4 or 24 h. These times allowed simple 
secretion of mediators due to cell/particle interactions 
(i.e., phagocytosis, contact; 4 h) to be differentiated 
from neo-synthesis of the mediators (24 h). Of note, all 
precursors used for HA powder synthesis are known to 
be biocompatible and endotoxin levels remained under 
the detection threshold of the commercially available 
kit (Kinetic Chromogenic LAL Assays, Lonza, Ver-
viers, Belgium). As a consequence, the inflammatory 
response of the detected monocytes was only attribut-
able to HA particles. Controls consisting of monocytes 
in culture medium and cell-free culture medium were 
performed. To assess the ability of the cells to induce 
an inflammatory response, monocytes were exposed 
to the well-known inflammatory positive control, 
lipopolysaccharide (1 μg.ml-1; Sigma-Aldrich).
Measurement of inflammatory mediator levels 
by ELISA
After 4 and 24 h, TNF-α, IL-1β, IL-6, IL-8 and IL-10 
concentrations were measured in cell culture superna-
tants using commercially available ELISA kits (Duo-
set®, R&D Systems, Lille, France) according to the 
manufacturer’s instructions.
Zymographic analyses
The expression and activity of two prometalloprotein-
ases (pro-MMP-2 and pro-MMP-9) in conditioned 
media of monocytes were analyzed by gelatin zymog-
raphy as previously described [36]. Pro-MMP-2 and 
pro-MMP-9 standards (Merck Millipore, Molsheim, 
France) were also incorporated as markers in each gel. 
Proteolytic activities were quantified as integrated opti-
cal density by Gelpro software analysis (Silk Scientific, 
UT, USA).
In vivo experiments
Both the procedure and animal treatment complied 
with the Principles of Laboratory Animal Care formu-
lated by the National Society for Medical Research. 
The studies were carried out in accredited animal facil-
ities at the University of Bordeaux (N°: A33–063–917) 
under authorization (N°: B3310023) of the French 
Ministry of Agriculture and were approved by the 
Animal Research Committee of Bordeaux University 
(C2EA-50). Inflammatory response of the seven HA 
powders was tested in a critical-size femoral condyle 
defect in eight-week-old female Balb/c mice (n = 4 per 
group). Powders were sterilized by 25 kGy of gamma 
irradiation. A 1.2-mm diameter defect was created with 
a dental microdrill (Thomas, Bourges, France), creat-
ing a defect of 11.3 mm3. It was rinsed with a solution 
of 0.9% (w/v) NaCl and either left empty or totally 
filled with one of the seven HA powders mixed with 
0.9% (w/v) NaCl. Although the material was mixed 
with physiological serum and could then be easily used 
to fill the defect, the mixture was solid enough to stay 
inside the defect, once all the muscles were put back in 
place. Therefore, no membrane was needed to avoid 
leakage of the biomaterial. Implants and surrounding 
tissues were recovered 14 days after surgery. Animals 
were euthanized by sodium pentobarbital overdose 
(Nembutal®, Ceva, Libourne, France). Four samples 
for each condition were fixed with 4% (w/v) parafor-
maldehyde in 0.1 M phosphate buffer pH 7.4 for 24 h 
at 4°C and processed for histology.
Histological & immunohistochemistry analyses
Decalcification was performed for 1 h in Rapid Decal-
cify Solution (DC3, Labonord, Templemars, France) 
and dehydration was followed by embedding in paraf-
fin. At least ten sections (4–6 μm in thickness) were 
obtained from each sample and stained with Masson’s 
Trichrome or according to standard procedure for Hem-
alun-Erythrosine-Saffron. For Masson’s Trichrome 
staining, slides were hydrated and stained in Mayer’s 
hemalun (Labonord) and rinsed in deionized water for 
5 min each before being exposed to Fuchsin Ponceau 
(1v/2v; Labonord) for 1 min. After 1 min in 3.5% (w/v) 
phosphomolybdic acid, slides were run through 1% (v/v) 
glacial acetic acid, 1% (v/v) light green (Labonord) for 2 
min, glacial acetic acid again and were then dehydrated 
and mounted with a toluene-based medium. Osteoid 
was stained in red, collagen and bone in green, cyto-
plasm in pink and cell nuclei in black. Hemalun-Eryth-
rosine-Saffron stains nuclei violet-black, cytoplasm 
pink, blood cells red and collagen fibers orange.
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Sections were evaluated with an Eclipse 80i 
microscope light microscopy (Nikon, Champigny-
sur-Marne, France). Pictures were captured using a 
DXM 1200 C CCD camera (Nikon). Semiquantita-
tive counting of blood vessels was performed with 
NIS-Elements D 4.1 software (Nikon).
The presence of CD68-positive cells 14 days after 
implantation indicating chronic inflammation was 
evaluated by immunohistochemistry for this trans-
membrane glycoprotein, belonging to the lysosomal-
associated membrane protein family. Paraffin was 
removed by two changes of toluene for 5 min. Hydration 
of the sections was obtained with decreasing percent-
ages of alcohol. Endogenous peroxidase was blocked by 
applying 3% (v/v) hydrogen peroxide in methanol for 
10 min. Antigen retrieval was performed by applying 
proteinase K (Life Technologies) for 10 min. Endog-
enous biotin was blocked using an avidin/biotin block-
ing kit (Life Technologies) before blocking unspecific 
antibody binding using Histostain®-SP kit (Life Tech-
nologies). A rat monoclonal antimouse CD68 antibody 
(Abcam, n° #53444, Cambridge, UK) was applied for 
1 h (1:100). A biotinylated secondary antibody and the 
enzyme conjugate were applied for 10 min, followed by 
3 min with the aminoethyl carbazol chromogen sub-
strate. All chemicals were provided within the Histos-
tain–SP kit (Life Technologies). Counterstaining was 
performed for 1 min with Mayer’s hemalun (VWR, 
Fontenay-sous-bois, France). Negative controls under-
went the same treatment but without application of the 
CD68-specific primary antibody. To quantify CD68-
positive cells, three different sections per animal 
joint were evaluated with an Eclipse 80i microscope 
light microscopy (Nikon) using NIS-Elements D 4.1 
software (Nikon).
Statistical analysis
The significance of the results was first assessed with 
nonparametric analysis of variance using the Kruskal–
Wallis test followed by post hoc pairwise tests. They 
were performed using an exact nonparametric and 
stratified permutation test (StatXact 7.0, Cytel Inc, 
MA, USA). We used nonparametric statistics owing to 
a lack of normal distribution of the assessed variables. 
Stratification allowed the impact of donor/animal 
variability to be taken into account. Differences were 
considered significant at p < 0.05.
Results
Characterization of the HA powders
The x-ray diffraction patterns of the products 
(Figure 1A) show that HA was obtained for all the tem-
plates. HA crystallinity clearly evolved with sintering 
temperature. In all cases, the diffraction peaks of 
the samples calcined above 500°C were sharper than 
those prepared at 300°C or not calcined, indicating a 
good crystallinity. Heat-treatment at 300°C induced 
a medium crystallinity characterized by narrower 
peaks and a higher signal/noise ratio while absence 
of calcination induced a poor crystallinity with few 
and broad peaks. This indicates an increase of crys-
tallinity with temperature (Table 1). Specific surface 
area and pore volumes decreased when samples were 
exposed to high temperature both for soft and hard 
templating. Measured pore diameters ranged from 
2.8 to 17.2 nm, demonstrating that nanoporous 
HA were indeed synthesized. Transmission electron 
micrographs of HA particles (Figure 1B–H) exhib-
ited crystallites of different sizes and shapes. Except 
for HA3 powder which exhibited square to round-
shaped crystallites (AR = 1.53) (Figure 1D), soft-tem-
plating led to rod-shaped particles (AR = 7.44, 5.57 
and 10.89 for HA1, HA2 and HA4, respectively) 
(Table 1). HA1 and HA2 crystallites demonstrated 
visible porosity and round endings whereas the edges 
of HA4 crystallites were sharper and their poros-
ity was not distinguishable (Figure 1B, C & E). Hard 
templating HA powders were also quite uniform in 
crystallites shape and size (AR = 2.05, 1.68 and 1.52 
for HA5, HA6 and HA7, respectively) (Table 1). HA5 
and HA7 were multifaceted (Figure 1F & H) whereas 
HA6 exhibited square to round shapes with very 
smooth edges (Figure 1G). All powders exhibited a 
negative ζ-potential value ranging from -23.3 to -5.5 
mV (Table 1). ICP-OES analyses demonstrated high 
variability in powder bioactivity as a function of the 
synthesis route (Figure 1I & J). Calcium was initially 
released by all the HA powders as early as 30 min 
after immersion in cell culture medium. After 4 h, all 
the soft templating HA powders induced a decrease in 
calcium concentration in the medium that could be 
attributed to the precipitation of calcium phosphate-
bearing phases in the vicinity of the powders. Pow-
ders HA5 and HA6 exhibited a similar but delayed 
phenomenon (after 12 h), whereas powder HA7 
seemed to be bioinert as calcium concentrations dem-
onstrated very few variations over time. After eight 
days of immersion, calcium concentrations seemed to 
reach a plateau in all HA powders (Figure 1I). Regard-
ing phosphorus concentration in the medium over 
time, the same patterns were observed as for calcium 
in all the powders except HA6, in which the phos-
phorus concentration decreased as early as 30 min 
after immersion (Figure 1J), then reached a plateau 
to a 84% decrease in phosphorus concentration after 
eight days in comparison to medium alone.
Concerning chemical composition, each particle 
could be considered as relatively homogenous since for 
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Figure 1. Physical and chemical properties of the seven calcium-phosphate powders (see facing page). X-ray 
diffraction patterns of the seven HA powders (A), representative transmission electron-micrographs of the seven 
calcium-phosphate powders [B–H] , HA1–7, respectively) and elemental concentration variation profiles (mean ± 
SEM of nine measurements) of Ca (I) and P (J) after 14 days of immersion in cell culture medium determined by 
inductively coupled plasma-optical emission spectroscopy. 
HA: Hydroxyapatite; P: Phosphorous; SEM: Standard error of the mean.
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both soft and hard templating the formation process 
of HA was based on a soft chemistry process known to 
give homogenous materials [37]. Even if template resi-
dues remain during the hard processing, they will be 
homogenously distributed. The percentage of residual 
template was previously determined by EDX. The 
samples HA5 and HA6 synthesized in silica templates 
contain less than 4% of metallic silicon before calcina-
tion and about 1% after calcination at 500°C while 
in the one (HA7) synthesized with carbon remained 
a fraction of calcium carbonate but not detrimental to 
the biocompatibility of the ceramic [26].
Effect of HA powders on production of 
inflammatory mediators
To determine whether the nanoporous HA pow-
ders could influence the production of inflammatory 
mediators by human monocytes, we performed ELISA 
measurements after 4 and 24 h of culture (Figure 2). 
We evaluated the effect of HA powders on the produc-
tion of proinflammatory mediators, namely TNF-α, 
IL-1β and IL-6. First, we measured IL-1β protein lev-
els (Figure 2A). IL-1β is a well-known proinflammatory 
cytokine that is involved in the foreign body immune 
response. Only HA5 powder exhibited after 24 h a 
significant fivefold increase in IL-1β concentration 
compared with the control.
IL-6 production by human monocytes (Figure 2B) is 
important for osteoclasts differentiation and therefore 
for the integration of biomaterials. HA6 and HA7 
powders induced a mean decrease of IL-6 concentra-
tion of 71 and 68%, respectively, after 24 h. On the 
contrary, sustained IL-6 concentrations were noted in 
HA4 powder-stimulated cell supernatants.
Finally, we measured variations in TNF-α produc-
tion (Figure 2C), since the latter is a potent activator 
of inflammatory cells, including monocytes and mac-
rophages and acts in concert with IL-6 to stimulate 
osteoclastogenesis. ELISA measurements underlined 
only a threefold increase in TNF-α concentration after 
24 h induced by HA5 powder.
To summarize, it appears that HA powders synthe-
sized by soft templating (HA1–4) do not induce any 
statistically significant production of proinflamma-
Table 1. Physicochemical characteristics of the seven nanoporous hydroxyapatite powders synthesized following soft 
templating procedure (soft) or hard templating procedure (hard) using nanoporous silica or carbon templates.
Sample/
template
Calcination 
(°C)
Specific 
surface area 
(m².g-1)
Calculated 
pore diameter 
(nm)
Calculated 
pore volume 
(cm3.g-1)
Crystallinity 
from XRD 
spectra
ζ-potential 
in water 
(mV)
Dimensions 
(nm)
Aspect 
ratio
HA1/soft 650 43 7.8 0.13 Good -13.6 L: 201 ± 19 7.4 ± 0.7
S: 27 ± 1
HA2/soft 650 59 13.2 0.32 Good -5.5 L: 135 ± 10 5.6 ± 0.5
S: 25 ± 2
HA3/soft 650 41 2.8 0.05 Good -10.6 L: 46 ± 13 1.5 ± 0.3
S: 31 ± 2
HA4/soft 300 145 17.0 0.49 Medium -8.6 L: 371 ± 60 10.9 ± 2.6
S: 65 ± 18
HA5/hard 
(silica)
– 90 13.9 0.36 Poor -15.3 L: 42 ± 8 2.1 ± 0.5
S: 22 ± 2
HA6/hard 
(silica)
500 22 17.2 0.09 Good -23.3 L: 54 ± 7 1.7 ± 0.3
S: 33 ± 2
HA7/hard 
(carbon)
500 31 12.5 0.11 Good -14.0 L: 22 ± 5 1.5 ± 0.3
S: 14 ± 1
The specific surface area was determined from the adsorption curves by the Brunauer–Emmet–Teller method while the pore size and volume were calculated from 
the desorption curves using the Barrett–Joyner–Halenda method. Aspect Ratio = L/S (mean ± SEM).
L: Long axis; S:Short axis; SEM: Standard error of the mean; XRD: X-ray diffraction.
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Figure 2. ELISA measurements of IL-1β, IL-6, TNF-α, IL-8 and IL-10 concentrations in unexposed or hydroxyapatite 
powder-exposed cell supernatants after 4 and 24 h. Data obtained for lipopolysaccharide stimulus are expressed 
as mean ± SEM for seven independent donors in inserted boxes. Red bar represents median value. Black bars 
represent 1st and 9th decile and limits of white (4 h) or grey (24 h) rectangles represent 1st and 3rd quartile. Black 
points represent maximum and minimum values. 
* p < 0.05 when compared with nonstimulated (control) cells.  
HA: Hydroxyapatite; SEM: Standard error of the mean.
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tory cytokines, whereas HA powders synthesized using 
hard templating exhibit different responses.
The production of IL-8 (Figure 2D), a major che-
mokine in leukocytes recruitment from the blood flow 
was further studied. IL-8 concentration in cell super-
natants was statistically increased only when mono-
cytes were exposed 24 h to HA powders synthesized by 
hard silica templating (HA5 and HA6; threefold and 
twofold mean variation, respectively).
To evaluate the anti-inflammatory properties of the 
powders, we then studied IL-10 production (Figure 2E), 
which is of particular importance since it downregu-
lates the production of IL-1β, TNF-α, IL-6 and IL-8 
in several cell types following their activation. ELISA 
data demonstrated that only HA5 powder induced a 
mean twofold increased IL-10 production by mono-
cytes after 24 h in comparison with the basal culture 
condition.
In light of these results HA1, HA2, HA3, HA4 and 
HA7 could be expected as good candidates for bone 
filling purpose, as they did not induce large amount 
of neither proinflammatory cytokines nor chemokines.
Effect of HA powders on gelatinolytic activity
Remodeling of the extracellular matrix is an essential 
component of tissue integration but is also a key prob-
lem in persistent inflammation due to biomaterials 
owing to the uncontrolled degradation of the extracel-
lular matrix by proteases. To determine the effect of HA 
powders on gelatinase secretion by human monocytes, 
conditioned media were analyzed by zymography. 
We found the presence of both pro-MMP-2 and pro-
MMP-9 in cell culture supernatants after 4 and 24 h 
(Figure 3A & D). After 4 h, quantification of gelatino-
lytic activities highlighted an increase in pro-MMP-2 
activity in culture supernatants of cells in contact with 
powder HA5 (1.74-fold compared with the control) 
(Figure 3B). A significant increased pro-MMP-9 activ-
ity with HA5 and HA6 powders (1.31-fold and 2.88-
fold, respectively) was also identified (Figure 3C) after 
4 h. After 24 h, pro-MMP-9 activity demonstrated a 
3.1-fold increase when cells were in contact with HA7 
powder (Figure 3F).
These results suggested that powders synthesized by 
soft templating could induce a beneficial bone matrix 
remodeling through moderate proteolytic activities 
while powders synthesized by hard templating could 
be deleterious due to an increase in such proteolytic 
activities.
In vivo integration of HA powders
To complement in vitro data with in vivo evaluation, 
the seven HA powders were used to fill critical size 
defects in mouse femoral condyles which were ana-
lyzed after 14 days. In control mice, no defect was 
created or the critical size defect was left empty. The 
empty defects exhibited a fibrous, nonmineralized and 
disorganized tissue (Figure 4A & C) in comparison to 
the condyles that were not treated (Figure 4B & D). The 
defect was of a critical size for this experiment since 
spontaneous regeneration of the surgical site was not 
seen after 14 days. Three different phenomena could 
be observed in operated mice: either the powder caused 
the formation of fibrous tissue, as normally occurs 
in the healing of wounds (called fibroplasia) as seen 
with HA1 (Figure 4E–H), necrosis as seen with HA5 
(Figure 5A–D) or the formation of fibrous tissue due 
to a foreign body reaction (called fibrosis) at different 
stages as seen with powders HA2, HA3, HA4, HA6 
and HA7 (Figures 4I–T & 5E–L). We first investigated the 
deposit of newly formed matrix, infiltration of inflam-
matory cells and duration of materials in place. All 
powders induced chronic inflammation. The chronic 
inflammatory reaction was characterized by lympho-
cytes and macrophages infiltrating the defect site. The 
fibroplasia caused by HA1 powder was comparable to 
the physiological one occurring in fracture healing, 
including bone repair and remodeling in contact with 
the biomaterial. This fibroplasia was characterized by 
the deposit of extracellular matrix and collagen syn-
thesized by fibroblasts, as well as the presence of osteo-
clasts, indicating a form of remodeling (Figure 4E–H). 
The fibrosis seen with HA2, HA3, HA4, HA6 and 
HA7 was accompanied by the excessive production of 
connective tissue (Figures 4I–T & 5E–L). HA2 and HA3 
induced inflammation with increased amount of fibro-
blasts and CD68-positive cells (Figure 4K–L & O–P), 
and a large deposit of collagenous tissue filling most of 
the defect in the case of HA3 (Figure 4M–P), causing 
higher cellularization and explaining the presence of 
neutrophils in situ. This extensive inflammatory reac-
tion was comparable with the reaction due to HA4 
(Figure 4Q–T). HA3 and HA4 showed the same level 
of inflammatory cells-mediated biomaterial resorption. 
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Figure 3. Gelatinolytic activity in unexposed or hydroxyapatite powder-exposed cell supernatants after 4 and 
24 h. (A & D) Representative gel images of seven independent experiments of gelatin zymography performed on 
cell supernatants after 4 and 24 h of culture, respectively. Transparent bands on the dark background correspond 
to pro-MMP-2 and pro-MMP-9 gelatinolytic activities. Pro-MMP-2 and pro-MMP-9 standards are on the right. 
(B & C) Effect of the seven HA powders on pro-MMP-2 and pro-MMP-9 gelatinolytic activities, respectively, after 
4 h of culture. (E & F) Effect of the seven HA powders on pro-MMP-2 and pro-MMP-9 gelatinolytic activities, 
respectively, after 24 h of culture. Shown are ratios of integrated optical density values of stimulated over 
nonstimulated (control) cells from seven donors quantified using Gelpro software. Red bar represents median 
value. Black bars represent 1st and 9th decile and limits of white rectangle represent 1st and 3rd quartile. Black 
points represent maximum and minimum values. 
*p < 0.05 when compared with nonstimulated (control) cells.  
HA: Hydroxyapatite.
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Figure 4. Histological sections of mice femur bearing critical size defect filled with hydroxyapatite powders 
synthesized by soft templating. Defects in control animals were left empty and sections were stained with 
Masson’s Trichrome (A & C). (B & D) show nonoperated mouse femur sections that were stained with Masson’s 
Trichrome. Defects filled with HA powders synthesized by soft templating (HA1: [E–H]; HA2: [I–L]; HA3: [M–P]; 
HA4: [Q–T]) stained by HES (E, G, I, K, M, O, Q, S) and Masson’s Trichrome (F, H, J, L, N, P, R, T). Premature 
bone (osteoid) within matrix deposit is stained in bright red and collagen fibers are stained in blue in Masson’s 
Trichrome sections. Fibrous tissues are stained in orange and red blood cells in vessels surrounded by epithelia 
are stained in red in HES sections. Cell nuclei are stained dark purple. Red stars highlight blood vessels and yellow 
stars the remaining biomaterial. 
HA: Hydroxyapatite.
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The foreign body reaction seemed less organized with 
HA3 and HA4 than with HA2. HA2 and HA3 cre-
ated a larger deposit of collagenous tissue as well as the 
strongest granular reaction, while this was less promi-
nent with HA5 and absent with HA1. HA6 and HA7 
induced a moderate chronic inflammatory reaction 
with fibroblasts and a few inflammatory cells in situ 
(Figure 5E–L). Cells in contact with HA5 underwent 
necrosis (Figures 5A–D), probably as a result of an exten-
sive inflammatory response to the biomaterial. Overall, 
HA1, HA6 and HA7 (Figures 4E–H & 5E–L) induced 
little infiltrate of inflammatory cells around the 
implanted biomaterials, while HA2 and HA3 induced 
a mild inflammation (Figure 4I–P) and HA4 and HA5 
triggered severe inflammation (Figures 4Q–T & 5A–D). 
Findings were similar with regard to the resorption 
properties of the powders: HA1 and HA6 showed little 
resorption while HA7 was fully retrieved in condyle 
sections (Figures 4E–H & 5E–L). HA2, HA3 and HA4 
were highly resorbed (Figure 4I–T) while HA5 was 
totally resorbed owing to more severe inflammation 
(Figure 5A–D). We then investigated neoangiogenesis 
in the defect sites. Tissues surrounding the defect site 
presented homogeneous vascularization in all condi-
tions (not shown). Unfilled defects and those filled 
with HA7 resulted in the smallest number of blood 
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Figure 5. Histological sections of mice femur bearing critical size defect filled with hydroxyapatite powders 
synthesized by hard templating. Representative histological sections of mice femur bearing critical size defect 
filled with hydroxyapatite powders synthesized by hard templating (HA5: [A–D]; HA6: [E–H]; HA7: [I–L]) stained 
by HES (A, C, E, G, I, K)  and Masson’s Trichrome (B, D, F, H, J, L). Premature bone (osteoid) within matrix deposit 
is stained in bright red and collagen fibers are stained in blue in Masson’s Trichrome sections. Fibrous tissues are 
stained in orange and red blood cells in vessels surrounded by epithelia are stained in red in HES sections. Cell 
nuclei are stained dark purple. Red stars highlight blood vessels and yellow stars the remaining biomaterial. 
HA: Hydroxyapatite.
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vessels (about 0.14–0.2 per mm2), of which the larg-
est measured only 17 μm in diameter (Figure 5I–L). 
HA2-6 showed comparable numbers of blood vessels 
(0.32–0.5 per mm2) but the largest diameters differed 
from 23 μm with HA2, HA3 (Figure 4I–P) and HA6 
(Figure 5E–H) to 35 μm with HA4 (Figure 4Q–T) and 
37 μm with HA5 (Figure 5A–D). The greatest number 
of vessels was seen with HA1 (1 per mm2) with diam-
eters ranging from 11 to 33 μm (Figure 4E–H), a figure 
comparable to vessels in nontreated samples.
Finally, the presence of immune cells in tissues 
surrounding the implanted materials was evalu-
ated by CD68 immunostaining (Figure 6A–G). The 
quantification revealed that all materials induced an 
increase in the number of CD68-positive cells per 
field (Figure 6I) in comparison to the control (no pow-
der in the critical size defect, Figure 6H). Interestingly, 
values for HA1, HA6 and HA7 remained below those 
for HA2–5.
These in vivo data (summarized in Table 2) show 
that HA1 and HA6 are the powders giving the best 
in vivo bone integration. They exhibited a moderate 
inflammatory response and a good neovasculariza-
tion. HA2-4 give more or less foreign body reactions 
or fibrosis but higher relatively to HA1 and HA6. HA5 
displayed the strongest granular reaction associated 
to cell necrosis. Finally, HA7 induced also a fibrotic 
response with little infiltrate of inflammatory cells but 
associated with a very low vascularization.
Discussion
To facilitate their biointegration, bone substitutes 
require appropriate physicochemical properties to 
counteract uncontrolled inflammatory response and 
to promote vascularization and bone deposition. The 
short-term inflammatory reaction ensures optimal inte-
gration in the bone tissue by increasing matrix remod-
eling and control of osteoclastogenesis while vascular-
ization ensures the supply of nutrients and oxygen that 
are needed for bone cells to synthesize bone matrix. 
These properties can be analyzed by in vitro or in vivo 
approaches. The potential integration of the material 
into the regenerating bone can be assessed in vivo but 
requires implantation and histological examination. 
Then, vascularization can be assessed by histology, 
while the presence of pro- and anti-inflammatory cyto-
kines demands extensive investigation in vivo. On the 
contrary, the inflammatory response can be more eas-
ily and quantitatively evaluated in vitro, by measuring 
cytokines and proteinases production.
In this study, the in vitro analysis evidenced proin-
flammatory cytokines production only when mono-
cytes were put in contact with the three powders made 
by hard templating methods. Comparing their in vitro 
www.futuremedicine.com 797future science group
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stimulating potential, HA5 can be considered to be 
more inflammatory compared with HA6 and HA7 
while the later exhibits the lowest response. This is 
directly related to their in vivo behavior where HA5 
induces a cellular necrosis, HA6 a moderate inflamma-
tory reaction compatible with bone regeneration and 
HA7 a little inflammatory reaction associated with an 
excessive production of connective tissue, a very lim-
ited neovascularization and an absence of resorption 
of the materials that impede their osteointegration. As 
a matter of fact, in vitro data obtained with materials 
made by hard templating seem to provide clues as to 
the fate of HA powders in vivo.
More surprising, materials prepared by soft tem-
plating approaches did not stimulate neither cyto-
kine production nor gelatinolytic activity while they 
induced in vivo moderate to high inflammatory 
reactions in vivo. This difference between in vitro 
and in vivo observations could be due in part to the 
complex cellular and tissular interactions arising 
in vivo which were not taken into consideration in 
our in vitro analysis. For example, since bone forming 
cells are able to produce and to respond to cytokines 
and chemokines [38,39], they could drive an in vivo 
osteointegration which was unexpected on the basis of 
in vitro data. Moreover, we used purified monocytes 
Figure 6. CD68 immunostaining of mice femur bearing critical size defect unfilled or filled with hydroxyapatite 
powders. (A–G) Representative pictures of CD68 immunostaining (brown staining) for cells in contact with the 
seven HA powders (HA1–HA7). (H) Representative photograph of CD68 immunostaining on unfilled critical size 
defect (control). (I) CD68-positive cell count per high power field, magnification ×40. Red bar represents median 
value. Black bars represent 1st and 9th decile and limits of white rectangle represent 1st and 3rd quartile. Black 
points represent maximum and minimum values. 
*p < 0.05 when compared with control. 
HA: Hydroxyapatite; hpf: High-power field.
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for short periods for our in vitro analysis. In vivo, these 
cells differentiate into macrophages and osteoclasts, 
each exhibiting its own pattern of cytokines produc-
tion that could be different from our findings in the 
present study.
As the integration in host tissue remains the major 
concern, our data demonstrate that HA1 and HA6 
are the most suitable powders to be used as bone fill-
ing materials. HA1 powder exhibited the greatest 
matrix deposition and initiated the most extensive 
osteoid formation. Moreover, it promoted the most 
effective angiogenesis in critical bone defects with 
minor leukocytes recruitment and biomaterial degra-
dation, despite the persistence of a few CD68-posi-
tive cells surrounding the particles. Similarly, HA6 
induced a moderate inflammatory reaction in a dense 
fibrous tissue with a low infiltration of CD68-positive 
cells, little resorption of the material and an effec-
tive angiogenesis with large blood vessels. This could 
be explained in part by IL-8 production detected in 
vitro with HA6 powder as it has been demonstrated 
to have a role in angiogenesis [40]. By comparison, 
HA2 promoted severe inflammation but has a good 
potential for osteosynthesis and neovascularization, 
HA3 and HA4 induced a comparable formation of 
mature neovessels but no bone neosynthesis, HA5 
induced cell necrosis and HA7 did not induce any 
host response.
In an attempt to correlate these observations with 
the physicochemical parameters of the powders, we 
can observe first that HA1 and HA6 belong to the 
group of highly crystallized particles although HA4 
and HA5, which were considered to be the least suit-
able for in vivo bone filling, were not sintered or were 
sintered at low temperature (300°C for HA4). They 
were poorly crystallized in comparison with the others 
(Figure 1A) and exhibited the highest specific surface 
area. As a consequence, the least crystallized powder 
(HA5) induced the most sustained and significant 
proinflammatory cytokines (IL-β, TNF-β) and che-
mokine (IL-8) production in vitro and the more nega-
tive host tissue response. In vivo, common features for 
HA4 and HA5 powders were little or no matrix depo-
sition, high resorption rate, leukocytes recruitment, 
inflammatory cells numbering and similar observa-
tions regarding vessel formation. As a consequence, 
our results demonstrating increased inflammatory 
recruitment and high biomaterial resorption for pow-
ders exhibiting the highest specific surface areas were 
expected and agreed with previous findings on host 
response to particles [18,41].
Increasing sintering temperature can also influ-
ence crystallite size [42]. Consequently, small dimen-
sions of HA5 crystallites could also explain the strong 
negative in vitro and in vivo response they induced. 
Interestingly, HA7 also displayed small-sized crystal-
lites. In this case, this limited crystallite growth was 
not due to a low sintering temperature but rather to 
the delayed oxidation of the template used, in other 
words, sucrose carbon template replicated from silica 
template that lead to smaller HA particles with lim-
ited grain growth [26]. Thus it appears that crystallite 
dimension could be a prominent factor for determin-
ing in vivo host responses of the nanoporous powders 
tested here.
Crystallinity is also known to influence the dis-
solution potential of HA crystallites [43]. The dis-
solution potential evaluated by ICP-OES effectively 
showed for all powders except HA7 an initial release 
of calcium and phosphate during the first 4 h fol-
lowed by a precipitation maintained until 8 days after 
immersion (Figure 1I & J). Importantly, HA5 pow-
der was the most active in Ca and P release in the 
ICP-OES assay. Indeed, Motskin et al. showed that 
a high rate of degradation of HA crystallites inside 
cells could impact cellular behavior (i.e., cell death) 
Table 2. Synthetic table of in vivo results.
Parameter  Control HA1 HA2 HA3 HA4 HA5 HA6 HA7
Global 
response
Fibrosis Fibroplasia Fibrosis Fibrosis Fibrosis Necrosis Fibrosis Fibrosis
Inflammation • • •• •• ••• ••• • •
Macrophages 0 • •• •• •• ••• • •
Material 
resorption
NA • •• ••• ••• ••• • 0
Number of 
vessels
• ••• •• •• •• •• •• •
Diameter of 
vessels
• •• •• •• ••• ••• •• •
0: None; •: Low; ••: Mild; •••: High; HA: Hydroxyapatite; NA: Not applicable.
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owing to calcium release, which is in agreement with 
our in vivo observations [19]. Moreover, this could also 
account for the high inflammatory potential of HA5 
powder under consideration, as intracellular calcium 
has also been found to induce cytokines production 
[44]. On the contrary, HA7 which was not bioactive 
as determined using ICP-OES and by evaluating the 
material remaining in vivo, was not proinflammatory 
both in vitro and in vivo but failed to induce host 
response in terms of tissue regeneration or vascular 
development, highlighting the importance of con-
trolled dissolution of the ceramics for optimized bone 
synthesis. It should also be noted that the powders 
tested here demonstrated a basal level of proteolytic 
activity in vitro. This is in agreement with previous 
data demonstrating no involvement of sintering tem-
perature or surface area ratio on human gelatinase 
production, whereas shape seemed to be an important 
factor for particle uptake and cytokines production 
by the cells [17,20].
HA4 being by far the most inflammatory powder 
in the soft templating group and being the only one 
to exhibit sharp-edge crystallites (Figure 1E), this sug-
gests a shape effect on the inflammatory response as 
previously demonstrated despite the absence of sig-
nificant variations in the production of inflammatory 
mediators in vitro [18]. However, since all other pow-
ders exhibited rather round- or rod-shape crystallites 
but with round edges, the shape of crystallites does not 
seem pertinent to discriminate among our powders. 
Similarly, the aspect ratio and dimensions of crystal-
lites are not pertinent since HA1 and HA6 were very 
different on these criteria while HA5 and HA6 were 
similar. Finally, with regard to previous work on the 
effect of sintering temperature on pH of zero charge 
and the production of inflammatory mediators by 
human monocytes [21], unexpectedly the ζ-potential 
did not seem to be involved in either cellular or animal 
responses, probably because the differences between 
the measured values were too small to impact particle 
agglomerates [45].
Conclusion & future perspective
Normally, a combined in vitro and in vivo approach 
could be a promising strategy to obtain data for 
each step of the inflammation cascade that governs 
the fate of an implant in a host. However, from our 
experiments it appears that in vitro experiments using 
solely monocytes seem insufficient for predicting the 
osteointegration of ceramic particles.
This study coupling both in vitro and in vivo 
approaches showed that among our seven nanopo-
Executive summary
Background
•	 Calcium phosphates and especially hydroxyapatite (HA) are widely used as bone substitute. So far, however 
nanoporous HA has been poorly explored.
•	 In host, HA is expected to induce inflammatory process as it is a first step in tissue repair. Inflammatory 
potential is generally analyzed either in vitro or in vivo but rarely together.
•	 The balance between pro- and anti-inflammatory factors in the vicinity of the implanted material is crucial for 
the control of angiogenesis, osteoclastogenesis, bone resorption, bone remodeling and tissue integration.
Materials & methods
•	 Seven different nanoporous HA produced by soft and hard templating were prepared.
•	 They were biologically evaluated thanks to a rarely combined approach using elutriated human primary 
monocytes in vitro and critical bone defect in mice to assess host response.
Results
•	 Only nanoporous HA made by hard templating affected cytokines production and matrix metalloproteinase 
production by human monocytes.
•	 In vivo inflammatory response was increased with poorly crystallized hydroxyapatites which were the most 
inflammatory in vitro.
•	 One nanoporous HA made by soft templating and one made by hard templating exhibited the best bone 
integration. They both exhibited high crystallinity, moderate resorption, low specific surface area and 
moderate to large crystallites with smooth edges.
Discussion/conclusion
•	 In vitro response was not directly predictive of in vivo behavior of nanoporous HA particles.
•	 The most critical physicochemical characteristics of nanoporous HA for bone integration were determined. 
Materials exhibiting high crystallinity with moderate desorption, low specific surface area and large 
crystallites with smooth shape must be preferred.
Future perspective
•	 Using the two selected nanoporous HA, namely HA1 and HA6, bone filling biomaterials with high drug 
delivery capacity could be considered without the induction of deleterious inflammatory process.
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rous HA powders synthesized by soft and hard tem-
plating, the one exhibiting poor crystallinity, small 
crystallite size and high specific surface area such 
as HA5 was the less suitable material as bone filler 
since it induced necrosis in vivo. Similarly, the one 
exhibiting high crystallinity, small crystallite size 
but low dissolution potential such as HA7 was also 
nonsuitable as behaving as an inert material. On the 
contrary, nanoporous powders exhibiting high crys-
tallinity, moderate dissolution potential, high crys-
tallite size with smooth shape such as HA1 and HA6 
appeared to be the most suitable materials as bone 
fillers.
Finally, it appears that among all the physicochem-
ical characteristics of these nanoporous HA, the most 
critical for their bone integration are the crystallinity 
that controls dissolution potential, the specific surface 
area, the crystallite size and shape.
This could be of primary importance with regard 
to calcium-phosphate particles developed to be used 
as vehicles for in situ compound delivery.
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